Expression of nuclear factor erythroid 2-related factor 2 (Nrf2) and peroxiredoxin 6 (Prdx6) proteins in healthy and pathologic placentas of human and rat

Acta Histochemica

Volumn 116, Issue 8, 2014, Pages 1289-1300

  Acar, Nuray ^a   Soylu, Hakan ^a   Edizer, Imren ^a   Ozbey, Ozlem ^a   Er, Hakan ^a   Akkoyunlu, Gokhan ^a   Gemici, Burcu ^b   Ustunel, Ismail ^a  

^a AKDENIZ UNIVERSITY   (Turkey)

^b NEAR EAST UNIVERSITY   (Turkey)

Author keywords

Human; IUGR; Nrf2; PE; Placenta; Prdx6; Rat

Indexed keywords

DEXAMETHASONE; GLYCOGEN; PEROXIREDOXIN 6; TRANSCRIPTION FACTOR NRF2;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CYTOTROPHOBLAST; DECIDUA; DOWN REGULATION; EMBRYO; ENDOTHELIUM CELL; FEMALE; FETUS WEIGHT; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOLOCALIZATION; IMMUNOREACTIVITY; INTRAUTERINE GROWTH RETARDATION; NONHUMAN; NORMAL HUMAN; OXIDATIVE STRESS; PLACENTA; PLACENTA WEIGHT; PREECLAMPSIA; PROTEIN EXPRESSION; RAT; STROMA CELL; SYNCYTIOTROPHOBLAST; TROPHOBLAST; VASCULAR ENDOTHELIUM; WESTERN BLOTTING;

RATTUS;

EID: 84940165605     PISSN: 00651281     EISSN: 16180372     Source Type: Journal    
DOI: 10.1016/j.acthis.2014.07.012     Document Type: Article

References (70)

1. Acar N., Korgun E.T., Ustunel I. Cell cycle inhibitor p57 expression in normal and diabetic rat placentas during some stages of pregnancy. Histol Histopathol 2012, 27:59-68.
2. Ahn J.H., Shin J.E., Chung B.Y., Lee H.M., Kang H.H., Chung J.W., et al. Involvement of retinoic acid-induced peroxiredoxin 6 expression in recovery of noise-induced temporary hearing threshold shifts. Environ Toxicol Pharmacol 2013, 36:463-471.
3. Aimot-Macron S., Salomon L.J., Deloison B., Thiam R., Cuenod C.A., Clement O., et al. In vivo MRI assessment of placental and foetal oxygenation changes in a rat model of growth restriction using blood oxygen level-dependent (BOLD) magnetic resonance imaging. Eur Radiol 2013, 23:1335-1342.
4. Almeida M., Han L., Ambrogini E., Weinstein R.S., Manolagas S.C. Glucocorticoids and tumor necrosis factor alpha increase oxidative stress and suppress Wnt protein signaling in osteoblasts. J Biol Chem 2011, 286:44326-44335.
5. Babat L.B., McLain R., Milks R., Ferrara L., Sohn M.J. The effects of the antiresorptive agents calcitonin and pamidronate on spine fusion in a rabbit model. Spine J 2005, 5:542-547.
6. Barker D.J. Fetal nutrition and cardiovascular disease in later life. Br Med Bull 1997, 53:96-108.
7. Benediktsson R., Lindsay R.S., Noble J., Seckl J.R., Edwards C.R. Glucocorticoid exposure in utero: new model for adult hypertension. Lancet 1993, 341:339-341.
8. Burton G.J., Jauniaux E. Oxidative stress. Best Pract Res Clin Obstet Gynaecol 2011, 25:287-299.
9. Burton G.J., Woods A.W., Jauniaux E., Kingdom J.C. Rheological and physiological consequences of conversion of the maternal spiral arteries for uteroplacental blood flow during human pregnancy. Placenta 2009, 30:473-482.
10. Chae H.Z., Chung S.J., Rhee S.G. Thioredoxin-dependent peroxide reductase from yeast. J Biol Chem 1994, 269:27670-27678.
11. Chigusa Y., Tatsumi K., Kondoh E., Fujita K., Nishimura F., Mogami H., et al. Decreased lectin-like oxidized LDL receptor 1 (LOX-1) and low Nrf2 activation in placenta are involved in preeclampsia. J Clin Endocrinol Metab 2012, 97:E1862-E1870.
12. Chowdhury I., Mo Y., Gao L., Kazi A., Fisher A.B., Feinstein S.I. Oxidant stress stimulates expression of the human peroxiredoxin 6 gene by a transcriptional mechanism involving an antioxidant response element. Free Radic Biol Med 2009, 46:146-153.
13. Cozzi V., Garlanda C., Nebuloni M., Maina V., Martinelli A., Calabrese S., et al. PTX3 as a potential endothelial dysfunction biomarker for severity of preeclampsia and IUGR. Placenta 2012, 33:1039-1044.
14. Crowther C.A., Harding J.E. Repeat doses of prenatal corticosteroids for women at risk of preterm birth for preventing neonatal respiratory disease. Cochrane Database Syst Rev 2007, CD003935.
15. Gandley R.E., Rohland J., Zhou Y., Shibata E., Harger G.F., Rajakumar A., et al. Increased myeloperoxidase in the placenta and circulation of women with preeclampsia. Hypertension 2008, 52:387-393.
16. Gluckman P.D. Editorial: Nutrition, glucocorticoids, birth size, and adult disease. Endocrinology 2001, 142:1689-1691.
17. Hay W.W., Catz C.S., Grave G.D., Yaffe S.J. Workshop summary: fetal growth: its regulation and disorders. Pediatrics 1997, 99:585-591.
18. Hemberger M., Cross J.C. Genes governing placental development. Trends Endocrinol Metab 2001, 12:162-168.
19. Hirota Y., Acar N., Tranguch S., Burnum K.E., Xie H., Kodama A., et al. Uterine FK506-binding protein 52 (FKBP52)-peroxiredoxin-6 (PRDX6) signaling protects pregnancy from overt oxidative stress. Proc Natl Acad Sci U S A 2010, 107:15577-15582.
20. Hung T.H., Burton G.J. Hypoxia and reoxygenation: a possible mechanism for placental oxidative stress in preeclampsia. Taiwan J Obstet Gynecol 2006, 45:189-200.
21. Ikeda H., Nishi S., Sakai M. Transcription factor Nrf2/MafK regulates rat placental glutathione S-transferase gene during hepatocarcinogenesis. Biochem J 2004, 380:515-521.
22. Iuchi T., Akaike M., Mitsui T., Ohshima Y., Shintani Y., Azuma H., et al. Glucocorticoid excess induces superoxide production in vascular endothelial cells and elicits vascular endothelial dysfunction. Circ Res 2003, 92:81-87.
23. Jones M.L., Mark P.J., Lewis J.L., Mori T.A., Keelan J.A., Waddell B.J. Antioxidant defenses in the rat placenta in late gestation: increased labyrinthine expression of superoxide dismutases, glutathione peroxidase 3, and uncoupling protein 2. Biol Reprod 2010, 83:254-260.
24. Kang S.W., Baines I.C., Rhee S.G. Characterization of a mammalian peroxiredoxin that contains one conserved cysteine. J Biol Chem 1998, 273:6303-6311.
25. Kobayashi A., Kang M.I., Okawa H., Ohtsuji M., Zenke Y., Chiba T., et al. Oxidative stress sensor Keap1 functions as an adaptor for Cul3-based E3 ligase to regulate proteasomal degradation of Nrf2. Mol Cell Biol 2004, 24:7130-7139.
26. Kweider N., Huppertz B., Wruck C.J., Beckmann R., Rath W., Pufe T., et al. A role for Nrf2 in redox signalling of the invasive extravillous trophoblast in severe early onset IUGR associated with preeclampsia. PLoS ONE 2012, 7:e47055.
27. Levitt N.S., Lindsay R.S., Holmes M.C., Seckl J.R. Dexamethasone in the last week of pregnancy attenuates hippocampal glucocorticoid receptor gene expression and elevates blood pressure in the adult offspring in the rat. Neuroendocrinology 1996, 64:412-418.
28. Liggins G.C., Howie R.N. A controlled trial of antepartum glucocorticoid treatment for prevention of the respiratory distress syndrome in premature infants. Pediatrics 1972, 50:515-525.
29. Lin F., Yu X., Zhang X., Guo Y., Huang Y., Zhou J., et al. A synthetic analog of lipoxin A4 partially alleviates dexamethasone-induced fetal growth restriction in rats. Placenta 2013, 34:941-948.
30. Lowry O.H., Rosebrough N.J., Farr A.L., Randall R.J. Protein measurement with the Folin phenol reagent. J Biol Chem 1951, 193:265-275.
31. Mando C., De Palma C., Stampalija T., Anelli G.M., Figus M., Novielli C., et al. Placental mitochondrial content and function in intrauterine growth restriction and preeclampsia. Am J Physiol Endocrinol Metab 2014, 306:E404-E413.
32. Manevich Y., Sweitzer T., Pak J.H., Feinstein S.I., Muzykantov V., Fisher A.B. 1-Cys peroxiredoxin overexpression protects cells against phospholipid peroxidation-mediated membrane damage. Proc Natl Acad Sci U S A 2002, 99:11599-11604.
33. Many A., Hubel C.A., Fisher S.J., Roberts J.M., Zhou Y. Invasive cytotrophoblasts manifest evidence of oxidative stress in preeclampsia. Am J Pathol 2000, 156:321-331.
34. McDonald T.J., Franko K.L., Brown J.M., Jenkins S.L., Nathanielsz P.W., Nijland M.J. Betamethasone in the last week of pregnancy causes fetal growth retardation but not adult hypertension in rats. J Soc Gynecol Investig 2003, 10:469-473.
35. McMahon M., Lamont D.J., Beattie K.A., Hayes J.D. Keap1 perceives stress via three sensors for the endogenous signaling molecules nitric oxide, zinc, and alkenals. Proc Natl Acad Sci U S A 2010, 107:18838-18843.
36. Myatt L., Cui X. Oxidative stress in the placenta. Histochem Cell Biol 2004, 122:369-382.
37. Neerhof M.G., Khan S., Synowiec S., Qu X.W., Thaete L.G. The significance of endothelin in platelet-activating factor-induced fetal growth restriction. Reprod Sci 2012, 19:1175-1180.
38. Ness R.B., Sibai B.M. Shared and disparate components of the pathophysiologies of fetal growth restriction and preeclampsia. Am J Obstet Gynecol 2006, 195:40-49.
39. Newnham J.P., Jobe A.H. Should we be prescribing repeated courses of antenatal corticosteroids?. Semin Fetal Neonatal Med 2009, 14:157-163.
40. Pak J.H., Manevich Y., Kim H.S., Feinstein S.I., Fisher A.B. An antisense oligonucleotide to 1-cys peroxiredoxin causes lipid peroxidation and apoptosis in lung epithelial cells. J Biol Chem 2002, 277:49927-49934.
41. Paula F.M., Ferreira S.M., Boschero A.C., Souza K.L. Modulation of the peroxiredoxin system by cytokines in insulin-producing RINm5F cells: down-regulation of PRDX6 increases susceptibility of beta cells to oxidative stress. Mol Cell Endocrinol 2013, 374:56-64.
42. Perez-Leal O., Barrero C.A., Merali S. Translational control of Nrf2 within the open reading frame. Biochem Biophys Res Commun 2013, 437:134-139.
43. Perkins A.V. Endogenous anti-oxidants in pregnancy and preeclampsia. Aust N Z J Obstet Gynaecol 2006, 46:77-83.
44. Radulescu L., Ferechide D., Popa F. The importance of fetal gender in intrauterine growth restriction. J Med Life 2013, 6:38-39.
45. Rajashree S., Puvanakrishnan R. Dexamethasone induced alterations in enzymatic and nonenzymatic antioxidant status in heart and kidney of rats. Mol Cell Biochem 1998, 181:77-85.
46. Redman C.W., Sargent I.L. Latest advances in understanding preeclampsia. Science 2005, 308:1592-1594.
47. Rhee S.G., Kang S.W., Netto L.E., Seo M.S., Stadtman E.R. A family of novel peroxidases, peroxiredoxins. Biofactors 1999, 10:207-209.
48. Roberts D., Dalziel S. Antenatal corticosteroids for accelerating fetal lung maturation for women at risk of preterm birth. Cochrane Database Syst Rev 2006, CD004454.
49. Roman A., Desai N., Rochelson B., Gupta M., Solanki M., Xue X., et al. Maternal magnesium supplementation reduces intrauterine growth restriction and suppresses inflammation in a rat model. Am J Obstet Gynecol 2013, 208:383.e1-383.e7.
50. Rosenbaum S., Ringseis R., Hillen S., Becker S., Erhardt G., Reiner G., et al. The stress signalling pathway nuclear factor E2-related factor 2 is activated in the liver of sows during lactation. Acta Vet Scand 2012, 54:59.
51. Rossant J., Cross J.C. Placental development: lessons from mouse mutants. Nat Rev Genet 2001, 2:538-548.
52. Scifres C.M., Nelson D.M. Intrauterine growth restriction, human placental development and trophoblast cell death. J Physiol 2009, 587:3453-3458.
53. Seckl J.R. Glucocorticoids and small babies. Q J Med 1994, 87:259-262.
54. Seckl J.R. Glucocorticoids, feto-placental 11 beta-hydroxysteroid dehydrogenase type 2, and the early life origins of adult disease. Steroids 1997, 62:89-94.
55. Seo M.S., Kang S.W., Kim K., Baines I.C., Lee T.H., Rhee S.G. Identification of a new type of mammalian peroxiredoxin that forms an intramolecular disulfide as a reaction intermediate. J Biol Chem 2000, 275:20346-20354.
56. Sibai B., Dekker G., Kupferminc M. Pre-eclampsia. Lancet 2005, 365:785-799.
57. Sugden M.C., Langdown M.L. Possible involvement of PKC isoforms in signalling placental apoptosis in intrauterine growth retardation. Mol Cell Endocrinol 2001, 185:119-126.
58. Sugden M.C., Langdown M.L., Munns M.J., Holness M.J. Maternal glucocorticoid treatment modulates placental leptin and leptin receptor expression and materno-fetal leptin physiology during late pregnancy, and elicits hypertension associated with hyperleptinaemia in the early-growth-retarded adult offspring. Eur J Endocrinol 2001, 145:529-539.
59. Taguchi K., Fujikawa N., Komatsu M., Ishii T., Unno M., Akaike T., et al. Keap1 degradation by autophagy for the maintenance of redox homeostasis. Proc Natl Acad Sci U S A 2012, 109:13561-13566.
60. Trainer P.J. Corticosteroids and pregnancy. Semin Reprod Med 2002, 20:375-380.
61. Tug N., Celik H., Cikim G., Ozcelik O., Ayar A. The correlation between plasma homocysteine and malondialdehyde levels in preeclampsia. Neuro Endocrinol Lett 2003, 24:445-448.
62. Uzan J., Carbonnel M., Piconne O., Asmar R., Ayoubi J.M. Pre-eclampsia: pathophysiology, diagnosis, and management. Vasc Health Risk Manag 2011, 7:467-474.
63. van Vliet E., Eixarch E., Illa M., Arbat-Plana A., Gonzalez-Tendero A., Hogberg H.T., et al. Metabolomics reveals metabolic alterations by intrauterine growth restriction in the fetal rabbit brain. PLoS ONE 2013, 8:e64545.
64. Vercruysse L., Caluwaerts S., Luyten C., Pijnenborg R. Interstitial trophoblast invasion in the decidua and mesometrial triangle during the last third of pregnancy in the rat. Placenta 2006, 27:22-33.
65. Waddell B.J., Hisheh S., Dharmarajan A.M., Burton P.J. Apoptosis in rat placenta is zone-dependent and stimulated by glucocorticoids. Biol Reprod 2000, 63:1913-1917.
66. Wang R., Paul V.J., Luesch H. Seaweed extracts and unsaturated fatty acid constituents from the green alga Ulva lactuca as activators of the cytoprotective Nrf2-ARE pathway. Free Radic Biol Med 2013, 57:141-153.
67. Wang X., Phelan S.A., Forsman-Semb K., Taylor E.F., Petros C., Brown A., et al. Mice with targeted mutation of peroxiredoxin 6 develop normally but are susceptible to oxidative stress. J Biol Chem 2003, 278:25179-25190.
68. Ware-Jauregui S., Sanchez S.E., Zhang C., Laraburre G., King I.B., Williams M.A. Plasma lipid concentrations in pre-eclamptic and normotensive Peruvian women. Int J Gynaecol Obstet 1999, 67:147-155.
69. Wruck C.J., Huppertz B., Bose P., Brandenburg L.O., Pufe T., Kadyrov M. Role of a fetal defence mechanism against oxidative stress in the aetiology of preeclampsia. Histopathology 2009, 55:102-106.
70. Zhang Y., Croft K.D., Mori T.A., Schyvens C.G., McKenzie K.U., Whitworth J.A. The antioxidant tempol prevents and partially reverses dexamethasone-induced hypertension in the rat. Am J Hypertens 2004, 17:260-265.